The estimated Net Worth of Stephen W Turner is at least 2.54 百万$ dollars as of 1 July 2011. Dr Turner owns over 67,900 units of Pacific Biosciences of California Inc stock worth over 1,722,274$ and over the last 13 years he sold PACB stock worth over 818,195$.
Sign up
Dr Turner PACB stock SEC Form 4 insiders trading
Dr has made over 1 trades of the Pacific Biosciences of California Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 67,900 units of PACB stock worth 818,195$ on 1 July 2011.
The largest trade he's ever made was selling 67,900 units of Pacific Biosciences of California Inc stock on 1 July 2011 worth over 818,195$. On average, Dr trades about 33,950 units every 0 days since 2011. As of 1 July 2011 he still owns at least 1,025,163 units of Pacific Biosciences of California Inc stock.
You can see the complete history of Dr Turner stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Stephen Turner biography
Dr. Stephen Turner is the Co-Founder & CTO at Pacific Biosciences of California Inc.
How old is Dr Turner?
Dr Turner is 53, he's been the Co-Founder & CTO of Pacific Biosciences of California Inc since . There are 9 older and 8 younger executives at Pacific Biosciences of California Inc. The oldest executive at Pacific Biosciences of California Inc is Lucy Shapiro, 79, who is the Independent Director.
What's Dr Turner's mailing address?
Stephen's mailing address filed with the SEC is PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1380 WILLOW ROAD, MENLO PARK, CA, 94025.
Insiders trading at Pacific Biosciences of California Inc
Over the last 14 years, insiders at Pacific Biosciences of California Inc have traded over 95,441,111$ worth of Pacific Biosciences of California Inc stock and bought 2,252,330 units worth 6,097,136$ . The most active insiders traders include Michael Hunkapiller、John F Milligan、Christian O Henry. On average, Pacific Biosciences of California Inc executives and independent directors trade stock every 44 days with the average trade being worth of 202,112$. The most recent stock trade was executed by Jeff Eidel on 19 August 2024, trading 26,760 units of PACB stock currently worth 42,548$.
What does Pacific Biosciences of California Inc do?
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
What does Pacific Biosciences of California Inc's logo look like?
Complete history of Dr Turner stock trades at Pacific Biosciences of California Inc
Pacific Biosciences of California Inc executives and stock owners
Pacific Biosciences of California Inc executives and other stock owners filed with the SEC include:
-
Michael Hunkapiller,
Director -
Christian O. Henry M.B.A.,
Pres, CEO & Director -
Susan G. Kim,
Chief Financial Officer -
Dr. Denis Zaccarin Ph.D.,
Sr. VP of R&D -
William Ericson,
Independent Director -
Randall Livingston,
Independent Director -
Marshall Mohr,
Independent Director -
John Milligan,
Independent Chairman of the Board -
Lucy Shapiro,
Independent Director -
Kathy Ordonez,
Director -
Christian Henry,
President, Chief Executive Officer, Director -
David Botstein,
Independent Director -
Susan Kim,
Chief Principal Officer, Chief Accounting Officer -
Eric Schaefer,
Chief Accounting Officer, Vice President -
Denis Zaccarin,
Vice President - Semiconductor Integration Devices -
Chris Seipert,
Vice President, Sales, Service & Support, EMEA and America -
Kathleen Lynch J.D.,
Head of Global Gov. Affairs & Corp. Communications -
Michele Farmer CPA,
VP & Chief Accounting Officer -
Kathleen Lynch,
Head of Global Gov. Affairs & Corp. Communications -
Brett Atkins J.D., Ph.D.,
Gen. Counsel & Corp. Sec. -
Trevin Rard,
Head of Investor Relations -
Dr. Jonas Korlach Ph.D.,
Chief Scientific Officer -
Michele Farmer,
VP & Chief Accounting Officer -
Mark Van Oene,
Chief Operating Officer -
Dr. Stephen Turner,
Co-Founder & CTO -
James Michael Phillips,
SVP, Research & Development -
Susan K Barnes,
EVP, CFO and PAO -
Kevin P Corcoran,
SVP, Market Development -
Brook H Byers,
Director -
Jeff Eidel,
See Remarks -
Brian B Dow,
VP and PAO -
Michael Glynn,
Chief Commercial Officer -
David B Singer,
Director -
Susan E Siegel,
Director -
Hugh C Martin,
Chairman, CEO & President -
Stephen W Turner,
VP & Chief Technology Officer -
Hannah Valantine,
Director -
Oene Mark Van,
See Remarks -
Peter Fromen,
See Remarks -
Michele Farmer,
See Remarks -
David W Meline,
Director